Park Ha Biological Technology Co Ltd (NASDAQ:PHH) price on Friday, July 25, fall -1.25% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.83.
A look at the stock’s price movement, the close in the last trading session was $0.84, moving within a range at $0.8037 and $0.8454. The PE ratio in trailing twelve months stood at 14.30. Turning to its 52-week performance, $41.49 and $0.82 were the 52-week high and 52-week low respectively. Overall, PHH moved -97.44% over the past month.
Park Ha Biological Technology Co Ltd’s market cap currently stands at around $21.83 million, with investors looking forward to this quarter’s earnings report slated for in August.
PHH’s current price about -93.16% and -94.87% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 26.33, while 7-day volatility ratio is 7.09% and 80.66% in the 30-day chart. Further, Park Ha Biological Technology Co Ltd (PHH) has a beta value of 0.
If we refocus on Park Ha Biological Technology Co Ltd (NASDAQ:PHH), historical trading data shows that trading volumes averaged 1.67 over the past 10 days and 1.49 million over the past 3 months. The company’s latest data on shares outstanding shows there are 25.00 million shares.
The 81.71% of Park Ha Biological Technology Co Ltd’s shares are in the hands of company insiders while institutional holders own 0.56% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.28 million on 2025-07-15, giving us a short ratio of 0.36. The data shows that as of 2025-07-15 short interest in Park Ha Biological Technology Co Ltd (PHH) stood at 1744.0000000000002 of shares outstanding, with shares short rising to 58992.0 registered in 2025-06-13. It is this reason that could see investor optimism for the PHH stock continues to rise going into the next quarter.
